Bellerophon Therapeutics, Inc. (BLPH) Stock Analysis
DELISTED 2024
What happened to Bellerophon Therapeutics, Inc. (BLPH) stock?
Bellerophon Therapeutics, Inc. (BLPH) no longer trades on public markets. It was delisted in December 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2024
- Last recorded price (historical):
- $0.012 (last quote on record before the December 2024 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Bellerophon Therapeutics, Inc. (BLPH). Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiopulmonary diseases. Their lead product candidate, INOpulse, is a proprietary pulsatile nitric oxide delivery system being investigated for various pulmonary hypertension indications.
Last analyzed: May 10, 2026Bellerophon Therapeutics, Inc. (BLPH) Healthcare & Pipeline Overview
More about this archive record
Can I still buy BLPH shares?
No. BLPH stopped trading on public markets in December 2024, so the shares are not available through a broker. Anything you see quoted for BLPH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BLPH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Bellerophon Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.